Last updated: August 06, 2026

Application No. 18/177,950

STEM CELL-PRODUCED MICROVESICLES FOR TREATING TENDON PATHOLOGIES

Non-Final OA

Filed

Mar 03, 2023

Priority

Aug 23, 2016 — provisional 62/378,392 +2 more

Examiner

FOX, ALLISON M

Art Unit

1633

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

New York R&D Center For Translational Medicine And Therapeutics Inc.

OA Round

1 (Non-Final)

Interview Optional

— +35.3% interview lift. Examiner has a relatively high allowance rate (71%); +35.3% interview lift. A written response may suffice.

Based on 669 resolved cases, 2023–2026

Examiner Intelligence

FOX, ALLISON M View full profile →

Grants 71% — above average

Career Allowance Rate

478 granted / 669 resolved

+11.4% vs TC avg

Strong +35% interview lift

Without

With

+35.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

31 currently pending

Career history

696

Total Applications

across all art units

Statute-Specific Performance

§101

7.1%

-32.9% vs TC avg

§103

28.9%

-11.1% vs TC avg

§102

16.4%

-23.6% vs TC avg

§112

27.5%

-12.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 669 resolved cases

Prosecution Timeline

Mar 03, 2023

Application Filed

Jul 31, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/704,662

Patent 12686880

METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS

4y 3m to grant Granted Jul 21, 2026

17/569,789

Patent 12680065

Artificial Placenta And Methods Of Preparation

4y 6m to grant Granted Jul 14, 2026

19/209,618

Patent 12673136

ENHANCED OSTEOINDUCTIVE COMPOSITIONS, SYSTEMS, AND METHODS OF MANUFACTURE

1y 1m to grant Granted Jul 07, 2026

17/739,466

Patent 12653843

Compositions Comprising Extracellular Matrix of Primitive Animal Species and Related Methods

4y 1m to grant Granted Jun 16, 2026

17/934,549

Patent 12655392

ENCAPSULATED LIVER TISSUE

3y 8m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

71%

Grant Probability

99%

With Interview (+35.3%)

3y 4m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 669 resolved cases by this examiner. Grant probability derived from career allowance rate.